Record results from Merck KGaA (2016)

German chemical-pharmaceutical group Merck KGaA reported today its 2016 financial results, which were beyond analysts’ expectations. Revenue increased by 17% to a record €15bn, with a €4.5bn EBITDA (+23,7 % vs 2015). Debt decreased by €1bn and EPS rose 27.5% vs 2015. Results from Life Science and Healthcare business sectors were highly positive (+6.3% and +4.5%).Performance Materials, instead, decreased by 1.8 %, delivering €2.5bn in revenue, probably because 2015 had been a record year for the sales of liquid crystals – the division’s real engine – and for the whole division. Despite this, the Darmstadt-headquartered group’s management strongly believes in the novel UB-FFS-T technology for smart phones, which already produced a double-figure growth in q4 2016. (Source: Merck)